UniSuper Management Pty Ltd Decreases Stock Position in Cardinal Health, Inc. (NYSE:CAH)

UniSuper Management Pty Ltd cut its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.4% in the 4th quarter, HoldingsChannel reports. The fund owned 24,688 shares of the company’s stock after selling 6,708 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Cardinal Health were worth $2,920,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of CAH. Cyrus J. Lawrence LLC purchased a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $26,000. Promus Capital LLC purchased a new stake in Cardinal Health during the 4th quarter valued at $30,000. Lee Danner & Bass Inc. bought a new stake in Cardinal Health in the 4th quarter worth $35,000. Kentucky Trust Co bought a new stake in Cardinal Health in the 4th quarter worth $41,000. Finally, HHM Wealth Advisors LLC increased its position in shares of Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after acquiring an additional 144 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on CAH shares. Mizuho began coverage on shares of Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price for the company. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. raised their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $136.43 on Friday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $137.18. The firm has a market cap of $32.96 billion, a price-to-earnings ratio of 25.45, a PEG ratio of 1.49 and a beta of 0.66. The company has a 50-day moving average of $128.36 and a 200 day moving average of $120.80.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.